Insights

More Articles Back to Article

WHO prequalifies Merck's Ebola vaccine

The World Health Organization has prequalified Merck's Ebola vaccine, VSV-EBOV, a day after the European Commission approved the treatment, which paves the way for groups such as Gavi, the Vaccine Alliance, and other agencies of the United Nations to stockpile and use the vaccine in at-risk countries. The vaccine is currently on compassionate use in the Democratic Republic of Congo as part of the preventive campaign to stall the spread of Ebola in the country. Center for Infectious Disease Research and Policy (11/12)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!